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Abstract
Objective—To determine the association of exposure to polycyclic aromatic hydrocarbons 
(PAHs) with lung function and pH of exhaled breath condensate (EBC) in Mexican 
schoolchildren.
Methods—A pilot study was performed in a subsample of 64 schoolchildren from Mexico City. 
Lung function and pH of EBC were measured and metabolites of PAHs in urine samples were 
determined. The association was analyzed using robust regression models.
Results—A 10% increase in the concentrations of 2-hydroxyfluorene was significantly 
negatively associated with forced expiratory volume in 1 second (−11.2 mL, 95% CI: −22.2 to 
−0.02), forced vital capacity (−11.6 mL, 95% CI: −22.9 to −0.2), and pH of EBC (−0.035, 95% 
CI: −0.066 to −0.005).
Conclusion—Biomarkers of PAHs exposure were inversely associated with lung function and 
decrease of ph of EBC as a marker of airway inflammation in Mexican schoolchildren.
Polycyclic aromatic hydrocarbons (PAHs) constitute a group of compounds composed of 
fused benzenoid rings and formed by incomplete combustion or pyrolysis of organic 
materials. Significant PAHs sources include motor vehicle exhaust, residential and industrial 
Address correspondence to Isabelle Romieu, MD, MPH, ScD, International Agency for Research on Cancer, 150 Cours Albert 
Thomas, 69372 Lyon Cedex 08, France (romieui@iarc.fr). 
The authors declare they have no conflicts of interest.
HHS Public Access
Author manuscript
J Occup Environ Med. Author manuscript; available in PMC 2015 October 14.
Published in final edited form as:
J Occup Environ Med. 2014 April ; 56(4): 415–419. doi:10.1097/JOM.0000000000000111.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
heating, waste incineration, and tobacco smoke. The PAHs with low molecular weight (two- 
and three-ring) are mainly found in the gas phase and those with high molecular weight 
(five- and six-ring) are mainly associated with particles in air.1 Smoking, grilling, and 
broiling lead to PAH formation in meat and in other foods. Considering the breadth and the 
variety of environmental sources, human exposure to PAHs occurs mostly through 
inhalation of polluted air and food consumption.2 Measurement of urinary metabolites 
reflects recent exposure to PAHs, and each parent PAH can produce more than one 
measurable urinary metabolite. In addition, both naphthalene and the insecticide carbaryl are 
metabolized to 1-hydroxynaphthalene, making it difficult to distinguish between these 
exposures in the general population,3 whereas only naphthalene metabolism results in 2-
hydroxynaphthalene in urine. Pyrene is commonly found in PAH mixtures, and its urinary 
metabolite, 1-hydroxypyrene, has been used widely as an indicator of exposure to PAH 
chemicals, particularly by occupational exposure studies.4
The PAHs have received increased attention in recent years because some are carcinogenic 
or mutagenic. Although the lighter compounds have weaker carcinogenic/mutagenic 
properties, they are the most abundant in the urban atmosphere.2 These compounds have 
also been associated with health outcomes unrelated to cancer, such as reproductive, 
cognitive, immunological, and respiratory effects.5
The Mexico City metropolitan area is a large polluted urban area with close to 85% of air 
pollutants coming from motor vehicles.6 Although particulate matter, specifically the 
inhalable or respirable fraction (PM10 and PM2.5), is routinely measured as an indicator of 
air pollution, PAHs are not frequently monitored and have been used much less as markers 
of air pollution.
Although exposure to fine particulates has been associated with fetal growth retardation, 
respiratory disorders, and cardiovascular disease, it is unknown whether PAHs contained in 
fine particulates are associated with these health effects.5,7 In Mexico City, the health effects 
from particulate matter have been well documented,8,9 but studies on exposure to PAHs and 
lung health have not been performed, to our knowledge. This study was undertaken to 
expand on our previous studies relating exposure to ambient air pollutants with respiratory 
health in children. We evaluated the association of urinary PAH metabolites with lung 
function and airway inflammation (measured as pH of exhaled breath condensate [EBC]) in 
these children. We hypothesized that acute exposure to PAHs is associated with decreased 
lung function and increased airway inflammation in this population.
Material and Methods
Study Design and Subjects
The children in the present cross-sectional pilot analysis were a subset (n = 64) of a larger 
cohort of 208 schoolchildren described previously.10 The subset of children attended 37 of a 
total of 107 schools represented in the larger cohort.
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Study Area
The study population consisted of schoolchildren living in three municipalities in the 
Mexico City metropolitan area with high levels of traffic-related emissions—Iztapalapa, 
Iztacalco, and Nezahualcoyotl.6 The 64 schoolchildren included in the present analysis were 
recruited from clinics at the Federico Gomez Children's Hospital of Mexico (Hospital 
Infantil de México Federico Gómez), one of the largest pediatric hospitals in the city. The 
children were between 6 and 14 years old; they lived in the study area, attended public 
schools located close to their homes, were volunteers, and were not selected using 
probability-based sampling. All procedures were explained to the parents, who signed an 
informed consent form. The children also gave their informed assent. The study protocol 
was reviewed and approved by the ethics committees at both the National Institute of Public 
Health (INSP, Spanish acronym) and the Federico Gomez Children's Hospital of Mexico. 
The involvement of the Centers for Disease Control and Prevention (CDC) laboratory was 
determined not to constitute engagement in human subject research.
Data Collection and Health Outcomes
A general purpose questionnaire was used to collect information on sociodemographic 
variables, past health history, and potential second-hand tobacco smoke exposure at home. A 
respiratory symptoms questionnaire was given, and anthropometric measurements were 
taken at baseline. The questionnaire has been used in previous studies in Mexican 
population and include some questions derived from the ISAAC standardized questionnaire. 
Lung function was measured using an EasyOne spirometer (NDD Medical Technologies, 
Andover, Massachusetts) according to the American Thoracic Society standards and EBC 
was collected using an R-tube following American Thoracic Society/European Respiratory 
Society Task Force recommendations. Spirometric test and EBC sampling methods and 
validation processes have been described in detail in our previous reports.8,11
Exposure Assessment
First morning urine samples were collected from schoolchildren. Containers were provided 
to the parents and they were instructed on sample collection procedures. The urine samples 
were refrigerated at 4°C and were then aliquoted and frozen at −70°C until the time of 
analysis. The urine samples were analyzed for monohydroxy PAH metabolites12 at the 
CDC. Creatinine concentrations were determined at the CDC laboratories by an enzymatic 
in vitro assay (Roche Diagnostic, Indianapolis, Indiana). Metabolites were reported as 
creatinine adjusted (ng/g creatinine). Urinary metabolite measurements in spot samples were 
routinely adjusted using creatinine to correct for urine concentration/dilution.13
Statistical Analyses
Geometric mean and percentiles for PAH biomarker levels were calculated. To compare 
subjects included in the analysis with those who were excluded, nonparametric tests on the 
equality of medians were performed. The associations of lung function and pH of EBC 
(dependent variables) with urinary PAH metabolite concentrations (independent variables) 
were analyzed by robust regression models. Models were run to evaluate exposure effects 
from the previous day. That is, the association was calculated by selecting the day that 
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pulmonary function was performed and assigning the urinary metabolite measurement from 
the previous day. Urinary PAH metabolites were log transformed to normalize the 
distribution. Models were adjusted for potential confounding factors including sex, age, 
second-hand smoke exposure at home, and body mass index. Other variables such as 
socioeconomic index (mother's education and school type), atopic status, the use of allergy 
medicine, diet, height, and season were not significant (P > 0.10) and did not alter the results 
by more than 1%. Also, different multipollutants models were tested; however, given the 
correlation between these measurements, we decided to present the results from a single 
pollutants model. Analyses were conducted using Stata software, version 10.1 (StataCorp 
LP, College Station, TX).
Results
Characteristics of participants versus nonparticipants are presented in Table 1. Fifty-nine 
percent were male, with a median age of 9.6 years, ranging from 6 to 13 years. The mean 
number of years for mothers' schooling was 8.4. Sixty percent of the children were exposed 
to second-hand tobacco smoke from an adult who smoked at home.
Urinary PAHs Biomarkers Data
Table 2 presents the descriptive statistics for the creatinine-adjusted concentrations of the 
nine monohydroxy PAHs—metabolites of fluorene, phenanthrene, pyrene, and naphthalene. 
Ninety-nine percent of the samples had levels higher than the limit of detection. Figures 1A 
to Figures 1B present a comparison of the PAH metabolite levels in this study with the 
results of 6- to 11-year-old children in the US National Health and Nutrition Examination 
Survey, which reported PAH biomarker levels from a statistically representative sampling of 
the US general population.14 For most of the metabolites measured, the geometric mean was 
similar to that in the US National Health and Nutrition Examination Survey, except for 2-
hydroxynaphthalene, 2-hydroxyfluorene, 9-hydroxyfluorene, and 2-hydroxyphenanthrene. 
The differences between these metabolites could not be explained by second-hand smoke 
exposure at home.
Association Between Health Outcomes and Urinary PAH Metabolites
The associations of urinary PAH biomarkers with lung functions and pH of EBC are shown 
in Table 3. We found a significant negative association of some urinary PAH metabolites 
with lung function and pH of EBC, after adjusting for age, sex, second-hand tobacco smoke, 
and body mass index. A 10% increase in the concentration of 2-hydroxyfluorene had a 
significant negative association with forced expiratory volume in 1 second (FEV1) (−11.2 
mL, 95% CI −22.2 to −0.02), forced vital capacity (FVC) (−11.6 mL, 95% CI −22.9 to 
−0.2), and pH of EBC (−0.035, 95% CI: −0.066 to −0.005) in schoolchildren. In the model 
for 1-hydroxyphenanthrene, we observed a marginally significant negative association with 
FEV1 (−7.8 mL, 95% CI: −17.1 to 1.5, P = 0.09) and FVC (−9.1 mL, 95% CI: −19.9 to 1.7, 
P = 0.09). The other PAH metabolites measured showed a negative association trend with 
lung function, but these associations were not statistically significant.
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Six out of the nine PAH metabolites were significantly associated with decreased pH of 
EBC, one was marginally associated, and 1-naphthal and 4-hydroxyphenanthrene were the 
only two metabolites that were not significantly associated with decreased pH of EBC 
(Table 3). For example, a 10% increase in 1-hydroxyphenanthrene concentration was 
associated with a decrease of −0.028 pH in EBC (−0.028, 95% CI: −0.047 to −0.010, P = 
0.005).
Discussion
The results of this pilot study showed that acute exposure to PAHs, as evaluated by its 
urinary metabolites, had a negative association with pH of EBC and lung function in this 
cohort of Mexican schoolchildren. Although exposure to outdoor ambient levels of PM2.5 
and other air pollutants has been associated with decreased lung function, asthma, and 
respiratory symptoms in schoolchildren, this is the first study that explores an association 
with the inflammatory response and changes in lung function due to exposure to low-
molecular-weight PAHs. A recently published study in Fresno, California, showed increased 
wheezing in asthmatic children exposed to PAHs, but this study measured air phenanthrene 
and 4-, 5-, and 6-ring particle-bound PAHs concentrations.15 Phenanthrene was found to 
have an impact on wheezing and our results also show that phenanthrene metabolite (1-
hydroxyphenanthrene) had a significant or marginally significant negative association with 
respiratory parameters.
Our results are also consistent with those reported in other studies relating PAH exposure to 
lung health. Certain hydrocarbons present in the environment, such as benzo(a)pyrene, can 
contribute to adduct formation in the lung. These adducts have occurred in bronchial 
epithelial cells and have been considered critical to effects on human lungs16–18, however, 
we did not have information on this metabolite in our population.
Early animal studies on the influence of particles and PAHs exposure show that risks from 
the carcinogenicity of PAHs increase with prolonged retention of these compounds in the 
lungs because of lipophilic properties.1 A major fraction (probably greater than 80%) of 
inhaled PAHs is expected to be deposited on the thin alveolar epithelium fraction and is 
likely to be retained in the lung tissue. Therefore, high local tissue concentrations can occur 
even with the low level of exposure to which humans are subjected, thereby inducing 
inflammatory processes.1 These negative effects observed on lung function and the decrease 
of pH of EBC as marker of inflammatory response of airways are consistent with those 
reported in our previous studies on vehicular traffic-related air pollution, suggesting a short-
term effect of particulate matter.
In our cohort study, PM2.5 levels ranged from 3.1 to 96.1 μg/m3 during the study period and 
were shown to affect both lung function and airway inflammation, evaluated by pH of 
EBC.8,11 For the present analysis, we performed an objective evaluation of PAHs exposure, 
using multiple urinary biomarkers, and our results are consistent with those observed for 
exposure to local PM2.5 concentration, for which we observed a reduction in FEV1 of 21 mL 
for each increment in interquartile range of the 8-hour moving average of PM2.5.11
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Another contribution of this study is the evaluation of pH of EBC; Patel et al19 recently 
reported that decreases in EBC pH, indicating increased airway inflammation. In this sense, 
we observed a significant negative association between pH of EBC in schoolchildren and 
increased levels of fluorene, phenanthrene, and naphthalene urinary metabolites. The results 
of this study for pH of EBC can be explained because exposure to PAHs has been shown to 
contribute to oxidative stress with increased secretions of proinflammatory cytokines and 
increases in the inflammatory response of the airways.20 In vivo experimental studies of 
PAH exposure have reported apoptotic activity and its potential association with the 
inflammatory response, prolonged inflammation, and delay in repair processes of injured 
tissues.21 Furthermore, Epton et al20 evaluated the pH of EBC and exposure to PAHs in 93 
male students but did not observe a significant effect of urinary 1-hydroxypyrene. In this 
study, 1-hydroxypyrene showed a significant association with decrease of pH of EBC, but 
not with lung function. Recently published results suggest that the pyrene metabolite has a 
large dietary component,22 whereas other PAHs—such as fluorene, and to a lesser extent 
phenanthrene—may be more related to air pollution exposure. We found that fluorene and 
phenanthrene metabolites were more highly associated with respiratory disease parameters, 
which is consistent with the fact that air pollution is a main source of PAHs in our 
population. Meanwhile, 4-hydroxyphenanthrene and 1-hydroxynaphthalene were not 
associated with any respiratory parameters, probably because of very low concentrations of 
the former and potential pesticide exposure as a competing source of 1-
hydroxynaphthalene.3
Some limitations must be taken into account when interpreting the results of this pilot study. 
First, we were only able to measure biomarkers for selected PAHs, while total PAH 
exposure includes large numbers of individual compounds in a given mixture. We could not 
evaluate exposure to high-molecular-weight PAHs, such as benzo[a]pyrene, because 
metabolites of the high-molecular-weight PAHs are difficult to detect in urine. Nevertheless, 
attention has recently focused upon the more abundant gas-phase PAHs, such as 
naphthalene, phenanthrene, and fluorene. Also, pyrene is normally abundant in PAH 
mixtures, and exposures occur through diet, polluted air, and cigarette smoke. In addition, 1-
hydroxypyrene has been widely used as a representative biomarker of PAHs exposures.14 
Second, our sample size limited the power of this study, which directly affects the statistical 
significance of some associations and finally the possible bias by study design. Nonetheless, 
these preliminary results suggest a negative association of PAHs, as measured by urinary 
metabolites, with the inflammatory response and lung function.
Conclusion
Our preliminary results suggest that exposure to certain PAHs in the general environment 
may have an acute negative association on lung function and pH of EBC in a subset of 
Mexican schoolchildren. To our knowledge, this is the first study in showing an association 
between decreased lung function, decrease of Ph of EBC, and PAH exposure, evaluated with 
urinary biomarkers. Nevertheless, specifically designed epidemiological studies are needed 
to confirm the effect of PAH inhalation exposure on lung health and to clarify a plausible 
biological mechanism.
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Figure 1. 
(A) 1-Hydroxynaphthalene (1-NAP) and 2-hydroxynaphthalene (2-NAP) urinary metabolite 
concentration* for the Mexican study population† and children from the US National Health 
and Nutrition Examination Survey (NHANES) 2003 to 2004.‡ (B) PAHs urinary metabolite 
concentration* for the Mexican study population† and children from NHANES 2003 to 
2004.‡ *Geometric mean (95% CI). †N = 64. ‡6 to 11 years. Data from CDC, 
Environmental Health, 2009.4
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